Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon.
about
Fenoldopam for preventing and treating acute kidney injuryFenoldopam for preventing and treating acute kidney injuryThyroid hormones for acute kidney injuryAtrial natriuretic peptide for preventing and treating acute kidney injuryUrine NGAL predicts severity of acute kidney injury after cardiac surgery: a prospective studyRole of kidney injury in sepsisNeutrophil gelatinase-associated lipocalin: pathophysiology and clinical applicationsRenal endothelial dysfunction in acute kidney ischemia reperfusion injuryUpdate on sepsis-associated acute kidney injury: emerging targeted therapiesInflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps.Therapeutic Targets of Human AKI: Harmonizing Human and Animal AKIA basic science view of acute kidney injury biomarkers.Slit2 prevents neutrophil recruitment and renal ischemia-reperfusion injuryDendritic cells tolerized with adenosine A₂AR agonist attenuate acute kidney injuryImmune mechanisms and novel pharmacological therapies of acute kidney injury.Divergent roles of sphingosine kinases in kidney ischemia-reperfusion injury.The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemia-reperfusion injuryTargeting sphingosine 1 phosphate receptor type 1 receptors in acute kidney injury.Ultrasound Contrast Agents in the Study of Kidney Function in Health and Disease.Atrial natriuretic peptide for management of acute kidney injury: a systematic review and meta-analysisInterleukin-11 protects against renal ischemia and reperfusion injury.Targeting Iron Homeostasis in Acute Kidney Injury.The reduction of Na/H exchanger-3 protein and transcript expression in acute ischemia-reperfusion injury is mediated by extractable tissue factor(s)Neutrophil gelatinase-associated lipocalin in dehydrated patients: a preliminary report.Resveratrol, a dietary polyphenolic phytoalexin, is a functional scavenger of peroxynitrite.Peptidyl arginine deiminase-4 activation exacerbates kidney ischemia-reperfusion injury.Serum and urine cystatin C are poor biomarkers for acute kidney injury and renal replacement therapy.Surgical sepsis and organ crosstalk: the role of the kidneyBiomarkers of AKI: a review of mechanistic relevance and potential therapeutic implications.Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury.Antithrombin nanoparticles improve kidney reperfusion and protect kidney function after ischemia-reperfusion injury.Inhibition of sphingosine 1-phosphate receptor 2 protects against renal ischemia-reperfusion injury.Some biomarkers of acute kidney injury are increased in pre-renal acute injury.Lysosomal protease cathepsin D; a new driver of apoptosis during acute kidney injury.Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion InjuryProximal tubule sphingosine kinase-1 has a critical role in A1 adenosine receptor-mediated renal protection from ischemia.A1 adenosine receptor allosteric enhancer PD-81723 protects against renal ischemia-reperfusion injuryPlasma neutrophil gelatinase-associated lipocalin predicts acute kidney injury, morbidity and mortality after pediatric cardiac surgery: a prospective uncontrolled cohort study.Serum uric acid and AKI: is it time?Sulfenic Acid Modification of Endothelin B Receptor is Responsible for the Benefit of a Nonsteroidal Mineralocorticoid Receptor Antagonist in Renal Ischemia.
P2860
Q24188272-EB856142-CDFF-4B6C-BE74-8BC650CB9A86Q24198276-E9FF6931-7549-44C7-B87C-1E426ABF2DADQ24201638-8875261E-0037-4F70-8C15-B2F23D2753DCQ24240285-DC42950B-8025-4867-8F69-C36AC15B75E9Q24654092-09D52DB8-0CE7-4D35-8E31-6EAC52697B5DQ26751630-6A6581BB-70DD-414D-A997-24C9CCA56DB7Q26824112-EC72C904-E4E2-4C33-924B-A888FFDD90FCQ26859947-DD98438D-89BC-42F4-B200-F96A672F832EQ28074631-546CB60C-C56A-41EF-B52E-E4D31BDB1AEBQ30278352-B5B952DA-9C83-4B2C-AE5D-0014CD33C254Q30278440-57570C1F-58D5-43CF-BB5A-B01B6AB733E3Q30384522-5EB92F2F-9572-43CA-8B50-037C8A1953BDQ30411659-C478CBB6-B340-497C-B50E-D5F7EB7DA942Q30423015-07C673BD-71C5-4EA5-B7DF-36511E503E79Q30434767-FCD1FA99-F613-4C83-A507-88C7BF2F8609Q30439331-220E4A2C-5DC2-4D75-AA15-0717A8E17C95Q30439547-CB2F726C-3FD9-4CE8-A3F8-38E80D9D4453Q30439643-EAB8F33F-5933-4B1F-8CE5-40BF20B6767DQ30440590-FDB2E028-2FBC-4217-B48D-9A0E4F9C0461Q33392153-F16F8476-E727-4720-BEB6-3C5566101242Q33402656-F66DFF90-BC44-4EB0-B869-2704A8C61502Q33712488-B7EC507F-A311-4B2D-9874-7CDAA6C55B29Q33924218-993A9310-2076-4B75-A721-E4F747192385Q34054084-9179B3DB-52C8-41C7-B887-7187DC3A7775Q34108098-91BB6801-0838-4E7C-8C51-42F85E7F9242Q34439789-3AC940E5-28F7-4386-8942-98374999D434Q34588093-34BC53E4-62AA-4576-85A9-2EB355D4C9EBQ34798883-6CDA653C-8107-4394-880A-C5053908561DQ34828809-EA8EA69F-B468-4F23-94C9-6E2072C76D88Q35132382-C3F00F79-61BF-4B0B-9126-84125530042BQ35274033-B9A6F130-0082-4F3D-A886-C9E6FBDCED3EQ35715879-D8E163E1-0FD5-4F84-B66E-D8FC060D4B55Q36001696-7D9FAF06-D590-4D00-80BE-BBB8144B9524Q36043544-C7F6B081-D18A-44DC-9AF6-3B6FC4A1C37AQ36104856-E0553C08-7237-45F5-B32D-BE864D7F4D93Q36237338-C806EBA1-B8F3-4C47-8A5B-6B16805BB284Q36309390-372E6D61-543E-438D-A8C8-219048DC6136Q36465429-849FD55C-FD95-4DF6-BF6B-9FCCE5B80F29Q36482934-E9B4187E-1F1A-408E-9129-81E06CEC7996Q36514942-1EBEEFDC-4B41-42BF-B767-065B4EADA9B9
P2860
Pharmacologic treatment of acute kidney injury: why drugs haven't worked and what is on the horizon.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@ast
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@en
type
label
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@ast
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@en
prefLabel
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@ast
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@en
P356
P1476
Pharmacologic treatment of acu ...... ed and what is on the horizon.
@en
P2093
Sang Kyung Jo
P304
P356
10.2215/CJN.03280906
P577
2007-01-17T00:00:00Z